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Abstract  
Enterococcus faecium MMRA is an enterocin A producer isolated from ‘Rayeb’, a Tunisian 
fermented milk drink. In this work, safety aspects and its behaviour in raw milk were 
investigated to assess its suitability as a protective adjunct culture. E. faecium MMRA showed 
interesting features such as the absence of several virulence traits, susceptibility to vancomycin 
and other clinically relevant antibiotics, and lack of haemolytic activity. To evaluate its 
performance as an adjunct culture for Rayeb, changes in the overall composition of control 
(non-inoculated) and experimental Rayeb (inoculated with 1 % v/v E. faecium MMRA) were 
determined throughout duplicate fermentations of raw milk using microbiological, chemical, 
HPLC and HSGC-MS analyses. E. faecium MMRA could multiply in raw milk and produced 
enterocin A. Interestingly, a higher content of volatile compounds including ethanol, diacetyl 
and 2-propanol was observed in the presence of this bacteriocin producer. Furthermore, this 
strain was capable of inhibiting the growth of Listeria monocytogenes CECT 4032 in 
pasteurized milk, although total killing was not achieved. Further experiments confirmed the 
development of resistant variants to enterocin A. On similar challenge assays, L. monocytogenes 
CECT 5672 growth was halted by the presence of the enterocin producer but viability was only 
slightly reduced during cold storage. According to our results, E. faecium MMRA meets the 
criteria for an autochthonous protective adjunct culture to enhance both the hygienic and the 
sensory attributes of Rayeb.  
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Introduction 
For centuries fermented products have played an important role in human nutrition. Traditional 
fermented dairy products vary considerably in composition, flavour and texture, depending on 
the properties of the fermenting organisms, type of milk, region of production and method of 
manufacture. These products have always proved very popular with consumers. Rayeb is one 
such popular indigenous dairy drink consumed in Tunisia, mostly in the summer as a dessert or 
refreshing beverage, and plays a major role in the diet of rural communities, as occurs with 
similar dairy products from other North African countries (Benkerroum & Tamime, 2004). 
Rayeb is traditionally made from the raw milk of cows, ewes or goats, placed in earthenware 
pots and kept undisturbed without temperature control for 24 h. It is produced through 
spontaneous fermentation of the milk, and is sometimes started via backslopping (inoculation of 
raw milk with a small quantity of the previous successful fermentation). On an industrial scale, 
it is produced from pasteurised cows’ milk, with the addition of starter cultures and rennet.  
Contamination by Listeria monocytogenes of traditional dairy drinks similar to Rayeb has 
been previously reported (El Marrakchi et al., 1993). Thus, the safety of this fermented beverage 
should be improved. Raw milk, in particular, is widely recognised as a source of L. 
monocytogenes contamination and a vehicle of listeriosis (Ryser, 1999). L. monocytogenes is the 
causative agent of a wide range of pathologies, ranging from gastroenteritis to meningitis and 
abortion with mortality rates of 20-30% and has long been recognized as one of the most 
important food safety issues to address (Aureli et al., 2000; Lundén et al., 2004; Cossart & 
Toledo-Arana, 2008). It is able to survive under severe physico-chemical conditions such as 
refrigeration temperatures, low pH values and high salt concentrations (Lou & Yousef, 1999), 
promoting persistence in foods and on food processing equipment. 
Due to the increasing demand for minimally processed foods, free from chemical additives, 
the use of bacteriocinogenic lactic acid bacteria (LAB) in food biopreservation has gained 
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widespread attention (Deegan et al., 2006; Gálvez et al., 2007). Among LAB, enterococci are 
known to produce a number of enterocins that can effectively inactivate food spoilage micro-
organisms and pathogenic bacteria such as L. monocytogenes, suggesting their role as 
‘protective’ bacteria (Giraffa, 1995). Enterococci are present in milk and several dairy products, 
particularly those produced in Mediterranean countries (Giraffa, 2002; Franz et al., 2003). 
Although their presence in dairy products has been regarded as an indicator of insanitary 
production methods, they have a long history of safe use (Foulquié Moreno et al., 2006; Ogier & 
Serror, 2008). Despite their beneficial effects on the sensory characteristics and the digestibility 
of dairy products, interest in the use of enterococci in starter cultures has somewhat diminished 
due to the fact that some strains may have virulence factors and antibiotic resistance genes 
(Foulquié Moreno et al., 2006). Moreover, biogenic amines produced by some enteroccocal 
strains are also a source of concern in the food industry, due to their toxigenic potential in 
humans (Bover-Cid et al., 1999). With this in mind, the selection of enterococcal strains for use 
in food fermentations requires a careful safety assessment (Ogier & Serror, 2008). 
We have previously isolated the strain Enterococcus faecium MMRA from traditional 
Tunisian Rayeb (Rehaiem et al., 2010). It synthesises the pediocin-like bacteriocin, enterocin A, 
a class IIa bacteriocin with strong anti-listeria activity (Aymerich et al., 1996). In the present 
study, we have assessed the suitability of this strain as a potential protective adjunct culture for 
the manufacture of the traditional Rayeb. Both safety and technological issues have been 
addressed. 
 
Material and Methods 
Bacterial strains and culture conditions 
Enterococcus faecium MMRA, an enterocin A producer, was previously isolated from home-
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made, traditional Tunisian ‘Rayeb’ (Rehaiem et al. 2010). It was routinely grown on M17 broth 
supplemented with 0·5% (w/v) lactose (LM17) (Scharlab, Barcelona, Spain) at 37 ºC for 18 h in 
aerobiosis. Listeria monocytogenes CECT 4032 and L. monocytogenes CECT 5672, used in 
challenge assays, were obtained from the Spanish Culture Collection (CECT) and propagated in 
Tryptone soya broth (TSB) (Difco laboratories, USA) at 37 ºC. Listeria innocua CECT 910 was 
used to detect enterocin A by the agar diffusion test, and was also grown in TSB at 37 ºC for 18 
h in aerobiosis (Rehaiem et al. 2010). A spontaneous mutant of E. faecium MMRA, resistant to 
rifampicin (Rif
r
) was obtained by plating 10
8
 cfu of an overnight culture on LM17 plus 100 
µg/mL rifampicin (Sigma Co, St. Louis, USA). This strategy has been successfully used in the 
past to allow differential enumeration (Rilla et al., 2003). E. faecium MMRA Rif
r 
was grown in 
UHT milk and incubated for 24 h at 37 °C to be used as protective adjunct starter. All the strains 
were stored at -80 ºC with 15% glycerol.  
 
Haemolytic activity, antibiotic resistance and enzymatic profile 
Haemolysin activity was determined by measuring zones of clearing on Columbia agar plates 
containing 5% (w/v) sheep blood (BioMérieux, Macy-L’Etoile, France) after 48 h of incubation 
at 37 °C. The susceptibility of the E. faecium MMRA strain to 23 commonly used antibiotics 
(Table 1) was performed by the disk diffusion
 
method on Muller-Hinton agar, according to the 
recommendations of the Comité
 
de l'Antibiogramme de la Société Française
 
de Microbiologie 
(2008) Antibiotic disks were obtained
 
from BioMérieux. The enzymatic profile was assayed 
using API Zym galleries (BioMérieux) according to the manufacturer’s instructions.  
 
PCR amplification 
PCR reactions to detect the presence of genes involved in the expression of the aggregation 
substance (agg), cytolysin (cylL), gelatinase (gelE), enterococcal surface protein (esp), and 
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hyaluronidase (hyl) were performed according to Gasson et al. (2001) with the primers listed in 
Table 2, using PuRe Taq Ready-to-go PCR Beads (GE Healthcare, Buckinghamshire, UK). 
DNA from E. faecalis FI9190 (Pérez-Pulido et al., 2006) and E. faecalis V583 (Paulsen et al., 
2003) was used as a positive controls for virulence traits. Likewise, PCR reactions to detect 
histidine (hdc) and tyrosine (tdc) decarboxylase genes were carried out in the same way using 
the appropriate primers (Table 2) and conditions as previously described (Le Jeune et al., 1995; 
Lucas & Lonvaud-Funel, 2002; Fernández et al., 2006). DNA from E. durans IPLA 655 
(Fernández et al., 2004) and E. faecalis V583 was used as a positive control for the hdc and tdc 
genes, respectively. 
 
Rayeb manufacture 
Fresh raw cow’s milk was supplied by a collaborative farm. Two batches of ‘Rayeb’ were 
manufactured in duplicate, with each vat containing 100 mL of raw milk. A 1% (v/v) overnight 
culture of the rifampicin resistant E. faecium MMRA (adjunct culture) was added to the 
experimental vats, while no adjunct culture was added to the control vats. Incubation was 
performed at 37ºC for 24 h. Samples were taken aseptically during the fermentation process at 
12 h and 24 h for further analyses as described below. Two independent trials were carried out. 
 
Microbiological analyses 
Samples of raw milk (10 mL) and Rayeb (10 g) were aseptically taken. Rayeb samples were 
homogenised in 90 mL of a prewarmed sterile 2% sodium citrate solution in a Stomacher Lab-
Blender (Seward Medical, London, UK). Decimal dilutions of milk and homogenates were 
made in quarter-strength Ringer solution (Merck KGaA, Damstadt, Germany) and plated on 
several different types of culture media. Total aerobic viable bacteria were pour plated on PCA 
agar (Scharlau Microbiology, Barcelona, Spain), total lactic acid bacteria on Elliker (EK) Agar 
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(Scharlau Microbiology), and coliforms on Violet Red Bile Agar VRBA (Biokar Diagnostics, 
Beauvais, France). Enterococci were spread plated on Kenner Fecal Agar (KF Agar) (Sharlau 
Microbiology) supplemented with 1% triphenyl tetrazolium chroride (TTC) (Scharlau Chemie, 
Barcelona, Spain) and KF agar supplemented with 100 μg/mL rifampicin (Sigma) was used for 
E. faecium MMRA Rif
r 
counting. KF and VRBA plates were further overlaid with 10 ml of the 
same medium. Depending on the medium requirements, plates were incubated for 48 h at 32 °C 
(PCA and EK) or 37 °C (VRBA and KF). Microbiological count data were expressed as log10 
CFU/mL and carried out in duplicate. To determine enterocin A activity, samples of Rayeb (1 g) 
were homogenised with 0.02 HCl (1:1, v/v) and centrifuged at 12,000 × g for 20 min at 4 ºC. 
The extracts were tested for bacteriocin activity against L. innocua CECT 910 by the agar 
diffusion test and expressed in mm to represent the zone of inhibition. 
 
Physicochemical analyses 
Acidity was measured by titration of milk and ‘Rayeb’ samples to pH 8.2 with 0.1 M NaOH 
(Panreac, Barcelona, Spain). Data were expressed as grams of lactic acid per 100 mL of sample. 
pH was measured with a MicropH 2001 pH meter (Crison, Barcelona, Spain). Dry matter, fat 
and protein content were determined according to IDF Standard 4A (1982), IDF Standard 152 
(1991) and IDF Standard 20B (1993), respectively.  
 
HPLC analysis and detection of volatile compounds.  
Major sugars and organic acids were determined by HPLC as described by Fernández et al., 
(2007). Briefly, 25 mL of 4.5 H2SO4 mM were added to 5 mL of milk or 5 g of Rayeb, extracted 
for 1 h, and centrifuged (12,000 × g, 5 min). Supernatants (50 μL) were isocratically separated 
in a 300×7.8 mm HPX-87H Aminex ion-exchange column (Bio-Rad Laboratoires, Inc., 
Hercules, CA, USA) protected by a cation H+ Microguard cartridge (BioRad), at a flow rate of 
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0.7 mL/min and a temperature of 65°C. Sulfuric acid (3 mM) was used as the mobile phase. 
Organic acid and sugars concentrations were determined using a chromatographic system 
composed of an Alliance 2690 module injector, a Photodiode Array PDA 996 and a 410 
Differential Refractometer detector, connected in series, and controlled by Millennium 32 
software (Waters, Milford, MA, USA). Solutions of organic acids and sugars were used as 
standards in the identification and quantification procedure. 
 
Analysis of volatile compounds 
Volatile compounds were determined by HSGC-MS according to Salazar et al., (2009). A 
G1888 headspace system (HS), connected to a Agilent 6890N gas chromatograph (GC) coupled 
to a 5975B inert mass selective detector (MSD) was used. Data were recorded and analysed with 
a ChemStation Software (Agilent Technologies, Santa Clara, CA, USA). Milk or curd samples 
(5 g) with cyclohexanone (0.36 mg/mL) as the internal standard and 5 g of anhydrous sodium 
sulphate were added into a 20 mL headspace glass vial, hermetically sealed. Samples in the HS 
were held for 30 min at 50 °C with stirring. Injections were made at a split ratio of 20:1, and the 
temperature was maintained at 220 ºC. Volatile compounds were separated on a HP-Innovax 
column (60 m × 0.25 mm, 0.25-μm film thickness). The chromatographic conditions were 35 °C 
for 5 min, a temperature increase of 5°C/min up to 100ºC and a second heating ramp of 8 ºC/min 
up to 240 ºC, held for 5 min. Helium was the carrier gas. Signals were recorded by the MSD by 
electron impact ionisation set at 70 eV operating in the scan mode. Volatile compounds were 
identified by comparing their mass spectra with those in the Wiley 138 library (Agilent). The 
peaks were quantified as the relative total ionic count abundance with respect to the IS. The 
concentration (μg/mL) of each volatile compound was calculated by using linear regression 
equations (R
2
 > 0.99) of the corresponding standards.  
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TLC analysis of biogenic amines  
Culture supernatants were obtained by centrifugation and their amine content determined by 
Thin-Layer Chromatography (TLC) as described by Garcίa-Moruno et al., (2005). Briefly, 
amines were converted to their fluorescent dansyl derivatives and fractionated on precoated 
silica gel 60 F254 TLC plates (Merck) in chloroform:triethylamine (4:1). The fluorescent dansyl 
derivative spots were visualized under UV-light (312 nm). 
 
 
Challenge assays 
Commercial pasteurised whole milk (Hacendado, Spain) was contaminated with overnight 
cultures of either Listeria monocytogenes CECT 4032 (aproximately 10
6 
CFU/mL) or L. 
monocytogenes CECT 5672 (aproximately 10
4 
CFU/ml). For each batch, one vat (100 mL) was 
used as control and a second vat (100 ml) was inoculated at 1% (v/v) with an overnight culture 
of E. faecium MMRA. The vats were incubated at 37 ºC for 24 h and were subsequently stored 
at 4 ºC for 2 days. Samples were aseptically taken at time intervals. For microbiological 
analysis, decimal serial dilutions in sterile Ringer solution were made and plated on Listeria 
selective Oxford agar containing Oxford selective supplement (Scharlau Microbiology) for L. 
monocytogenes enumeration, and on KF to quantify E. faecium MMRA. Plates were incubated 
for 48 h at 37 °C. Aliquots of co-cultures were also centrifugated at 12000 × g for 10 min, and 
the supernatants were tested for bacteriocin activity by the agar diffusion test against L. innocua 
CECT 910. Two independent challenging experiments were carried out. 
 
Statistical analysis 
It was performed using the SPSS-PC+11.0 software (SPSS, Chicago, IL, USA). Data related to 
microbiological counts, pH, acidity, gross composition (dry matter, fat and protein content), 
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carbohydrate consumption, organic acid and volatile compounds production were subjected to 
one-way ANOVA using two factors: ‘type of Rayeb’ with two categories (control and 
experimental) and ‘incubation time’ with three categories (0, 12 and 24 h). The least significant 
difference (LSD) test (P<0.05) was applied for means comparison. 
 
Results and Discussion 
The role of enterococci in food fermentations is not yet fully understood. They are ubiquitously 
distributed in traditionally fermented products and contribute positively to the sensory attributes. 
However, they may pose a risk as a potential reservoir of antibiotic resistance and virulence 
genes which could be transferred to human strains in the gastrointestinal tract. Therefore, it is 
mandatory that prior to any application in food, future starters or adjunct cultures undergo a 
careful screening to consider the safety and technological issues on a case-by-case basis (Ogier 
& Serror, 2008). On the other hand, it should be noted that food borne pathogens have been a 
continuous concern and can pose a serious health risk for consumers, L. monocytogenes being 
one of the common pathogens in milk and fermented milk products (WHO, 2007). Since the use 
of bacteriocin-producing strains can be a nice strategy to fight against undesirable bacteria 
(Gálvez et al., 2007), the high bacteriocinogenic potential of enterococci may play a protective 
role against L. monocytogenes in traditional fermented dairy products. Accordingly, in this 
work, we have focused on the enterocin A producer E. faecium MMRA, previously isolated 
from Rayeb, as a potential protective adjunct dairy culture. To our knowledge, no such studies 
have been done to assess the suitability of any LAB strain isolated from the traditional Tunisian 
Rayeb. 
 
Preliminary safety assessment of E. faecium MMRA 
Prior to evaluating the feasibility of the enterocin A producer E. faecium MMRA as a protective 
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adjunct culture for the elaboration of ‘Rayeb’, several risk factors were assessed. The presence 
of genes coding for five virulence factors, often found among enterococci, as well as those 
coding for amino acid decarboxylases involved in the synthesis of biogenic amines, was checked 
by PCR (Table 2). None of the potential virulence genes, including those coding for the 
aggregation pheromone (agg), hyaluronidase (hyl), and enterococcal surface protein gelatinase 
(esp), which are supposed to contribute to host colonization or hydrolysis of host proteins, could 
be amplified.  
An exception was the amplification of tdc coding for the tyrosine decarboxylase enzyme, 
involved in tyramine production (Table 2). This is not surprising as tyramine is the biogenic 
amine most frequently produced by enterococci that have been isolated from dairy products 
(Bover-Cid et al., 1999; Sarantinopoulos et al., 2001). However, this biogenic amine was neither 
detected by TLC in overnight LM17 culture supernatants nor in Rayeb samples inoculated with 
E. faecium MMRA. It is conceivable that during the short fermentation time needed for Rayeb 
manufacture, the proteolytic activity of E. faecium MMRA and that of the indigenous 
microbiota is not high enough to reach the free tyrosine threshold that triggers tyramine 
production (Linares et al., 2009).  
E. faecium MMRA was shown to be not haemolytic when grown on sheep blood agar (data not 
shown) and was susceptible to several β-lactams, aminoglycosides, and other broad-spectrum 
antibiotics (Table 1). Of note, E. faecium MMRA was susceptible to the glycopeptide 
vancomycin. This is of special interest as it is used as a last resort antibiotic against multiple 
antibiotic resistant enterococci (Klein, 2003; Franz et al., 2003; Ogier & Serror, 2008). The 
strain displayed intermediate resistance to some cephalosporins and resistance to oxacillin 
(Table 1). Thus, the antibiotic susceptibility profile of E. faecium MMRA is in agreement with 
previous reports concerning strains of enterococci that are commonly found in foods 
(Valenzuela et al., 2008; Barbosa et al., 2009; Ben Belgacem et al., 2010).  
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The enzymatic potential of the strain was evaluated using API ZYM strips (Table 1). 
Both Leucine and valine aminopeptidase, and alkalin and acid phosphatase, showed the 
strongest activities, while relatively weak esterase and protease activity was observed. E. 
faecium MMRA showed neither lipase nor potentially procarcinogenic activities (β-
glucuronidase and β-glucosidase). 
Overall, this preliminary safety assessment of E. faecium MMRA supports the notion 
that foodborne E. faecium poses a low risk when used in foods, since they are generally free of 
virulence determinants, or these determinants are found less frequently than in other 
enterococcal species (Gasson et al., 2001; Franz et al., 2001; Mannu et al., 2003; Abriouel et al., 
2008).  
 
Performance of E. faecium MMRA as an adjunct culture in Rayeb production 
Preliminary assays had shown that E. faecium MMRA could grow up to 8.5 log10 CFU/ml and 
synthesise enterocin A in pasteurized milk, with slight acidification down to pH 6 within 24 h 
(our unpublished results). However, Rayeb is commonly made with raw milk, in which the 
autochthonous microbiota could hinder the development of any starter or adjunct culture. 
Therefore, two batches of Rayeb made of raw milk were manufactured to evaluate the viability 
and the technological performance of the enterocin A producer. To differentiate E. faecium 
MMRA from endogenous enterococci, a spontaneous rifampicin resistant mutant (MMRA Rif
r
) 
was used to inoculate raw milk in the experimental vat (7.76 ± 0.8 log10 CFU/ml). A non-
inoculated raw milk vat was used as control. The vats were incubated at 37 ºC for 24 h. It should 
be noted that the Rif
r 
strain displayed similar growth properties and enterocin A production to 
the parent strain in both LM17 and pasteurized milk (data not shown). 
With regards to the physicochemical analyses, a similar pH, titratable acidity and gross 
composition (dry matter, fat, protein) was recorded in both control and experimental Rayeb after 
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24 h of incubation (P>0.05) (Table 3). Thus, the presence of E. faecium MMRA did not seem to 
disturb either the spontaneous fermentation of raw milk or the gross composition of the 
fermented raw milk. 
Counts of the major bacterial populations, namely total viable counts, lactic acid bacteria, 
coliforms and enterococci, throughout Rayeb fermentation, are shown in Table 4. The adjunct 
strain E. faecium MMRA Rif
r
 in the experimental vat showed good growth in milk and 
consistently higher microbial counts on PCA and EK culture media were observed relative to the 
control at 12 (P<0.05) and 24 h (P<0.01) of incubation. The same applied for the enterococcal 
population as counted on KF agar, which reached a population 3.8 log10 higher (P<0.001) in the 
experimental Rayeb at 24 h. Based on the similar counts on KF with and without rifampicin, we 
presumed that E. faecium MMRA Rif
r
 was the main enterococcal strain present in the 
experimental vats. However, despite the fact that indigenous rifampicin resistant enterococci 
were below the limit of detection (<10 CFU/mL) in raw milk samples, they were detected after 
incubation in control Rayeb. Nonetheless, this was 6 log10 units lower than was observed in 
experimental Rayeb (P<0.001). Bacteriocin activity was only detected in experimental Rayeb 
(Table 3). This issue is relevant as bacteriocin production may be hampered in a complex food 
environment such as raw milk, as shown for E. faecium FAIR-E 198 (Sarantipoulos et al., 2002). 
The total viable counts, coliforms and enterococci detected in raw milk are indicative of poor 
hygienic quality. Nevertheless, the decrease in pH (and the increase in acidity) likely contributed 
during fermentation to reduce the number of coliforms by 1.01-1.42 log10 CFU/mL in 24 h in 
both control and experimental vats. In fact, low pH is indeed a major hurdle in food preservation 
(Leistner 2000). However, the hygienic conditions of the fermented drink seemed to improve in 
the presence of E. faecium MMRA since a lower level of coliforms was detected, although not 
statistically significant (P>0.05). Considering that enterocin A is not active against Gram 
negatives, it is possible that a synergistic effect among different preserving compounds takes 
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place when the enterocin A producer is added to raw milk. Besides low pH, the higher diacetyl 
content detected in experimental Rayeb (see below) could have contributed largely because 
Gram-negative bacteria are particularly sensitive to this volatile compound (Jay, 1982). 
 
Enhancement of the sensory attributes of Rayeb using E. faecium MMRA as an adjunct culture 
From a technological point of view, selection of LAB in the dairy industry is mostly based on 
their ability to acidify and produce aromatic compounds (IDF Standard 149, 1991). Therefore, 
residual lactose, minor carbohydrates (glucose and galactose) and organic acids were also 
quantified throughout the Rayeb fermentations (Table 5). Incorporation of the strain MMRA as 
an adjunct culture did not seem to affect carbohydrate metabolism, as comparable values of 
lactose consumption (about 30%) were observed in both the control and experimental 
fermentations (P>0.05). Additionally, glucose was completely metabolized and similar levels of 
galactose occurred in both fermented milks (P>0.05). Accordingly, lactic acid production 
followed a similar pattern regardless of the presence of E. faecium MMRA (P>0.05), and 
accounted for over 90% of the carbohydrates consumed. Similar content of formic acid was also 
detected in the control and experimental Rayeb (P>0.05) (Table 5) As lactic acid production by 
the indigenous LAB microbiota is a critical parameter to ensure safe and successful raw milk 
fermentation, our results highlight the compatibility between the indigenous lactic acid bacteria 
and E. faecium MMRA.  
Interestingly, citric acid, an important precursor for aroma development, was completely 
consumed after 24 h in both fermented milks (Table 5). Citrate fermentation gives rise to several 
volatile carbonyl compounds (mainly diacetyl) which greatly contribute to the organoleptic 
properties of the fermented products. Accordingly, diacetyl was detected in both control and 
experimental Rayeb but the relative abundance was notably higher in the presence of the adjunct 
starter strain from 12 h onwards (P<0.001) (Fig. 1). The inoculation of raw milk with E. faecium 
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MMRA also resulted in a higher production of ethanol (P<0.05) (Fig. 1). It is also worth noting 
that another alcohol, 2-propanol, was only detected on the experimental Rayeb (P<0.001) (Fig. 
1). Other volatile compounds such as 2-propanone and acetoin were also detected in Rayeb 
whether or not the enterococcal strain was present. Therefore, E. faecium MMRA seemed to 
potentially enhance the aroma of Rayeb. Moreover, this strain can hydrolyze lactose via ß-
galactosidase and exhibited high peptidase activity, mainly leucine and valine aminopeptidase 
(Table 1), which may further contribute to a better flavour and texture of dairy products (Arora 
et al., 1990). Similarly, other E. faecium strains isolated from dairy foods have been reported as 
active contributors to sensory characteristics of fermented dairy products (Andrighetto et al., 
2001; Sarantinopoulos et al., 2001). 
 
Inhibition of L. monocytogenes by E. faecium MMRA in milk 
As far as we know, no published data exist on the incidence of L. monocytogenes in Tunisian 
Rayeb. However, studies in other Arab countries revealed the presence of L. monocytogenes in 
raw milk and traditional Raib (moroccan name for Rayeb) with up to 10% of samples being 
contaminated (El Marrakchi et al., 1993). More recently, L. monocytogenes has been detected in 
2.61% of raw milk samples from algerian farms (Hamdi et al., 2007). Considering the protective 
role of enterocins in food preservation (Khan et al., 2010) and once established that E. faecium 
MMRA did not disturb Rayeb fermentation, we proceeded to carry out challenge experiments to 
determine if it could inhibit the growth of L. monocytogenes in milk (presumably through 
production of enterocin A), providing a natural hurdle for protecting this traditional dairy 
product.  
Challenge experiments were performed in pasteurised milk which was incubated at 37 °C for 
24 h, and subsequently kept at 4 ºC for two days to mimic storage conditions. Milk was 
contaminated with either L. monocytogenes CECT 4032 (approximately 10
6
 CFU/mL) or L. 
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monocytogenes CECT 5672 (approximately 10
4
 CFU/ml). These two strains were chosen on the 
basis of their dairy origin and their different susceptibilities to enterocin A. L. monocytogenes 
CECT 4032 was inhibited by 1.28  104 AU/mL while L. monocytogenes CECT 5672, more 
resistant, was inhibited by 2.56  104 AU/mL. 
The fate of these two strains of L. monocytogenes was followed in the presence and absence 
of the adjunct E. faecium MMRA (Fig. 2). In both challenge assays, E. faecium MMRA grew 
during the incubation at 37 ºC and the population remained viable throughout cold storage (Fig. 
2). Enterocin A was detected at 24 h in the experimental Rayeb and remained stable during cold 
storage for two days. As expected, no bacteriocin activity was detected in control Rayeb (Fig. 
2). Cocultures of L. monocytogenes CECT 4032 and CECT 5276 with the enterocin A producer 
in milk resulted in a pH decrease from 6.65 at the inoculation time to 5.17 and 5.49, 
respectively, at 24 h. In both cases, the level of enterocin A detected, correlated to the growth of 
the producer strain.  
Growth of L. monocytogenes CECT 4032 occurred in the absence of E. faecium MMRA, the 
viable counts reaching 10
9
 CFU/mL in the first 24 h, and even increased further during cold 
storage (Fig. 2a) but counts were markedly reduced from 106 to 102 CFU/mL in 24 h (P<0.001) 
and further on during the 2 days of storage in the presence of the enterocin A producer 
(P<0.001). However, total clearance of the pathogen was not achieved (Fig. 2a). Additional 
experiments were performed to understand why L. monocytogenes CECT 4032 was not 
completely inhibited despite their susceptibility to enterocin A. For this purpose, we randomly 
chose four representative colonies from the Oxford counting plates and tested their susceptibility 
to enterocin A by the agar diffusion test. No zones of inhibition were observed on any of them, 
demonstrating that the surviving Listeria cells had become resistant (data not shown). This is not 
a surprising result since natural resistance by Listeria strains against class IIa bacteriocins such 
as enterocin A has been previously reported (Ennahar et al., 2000). Susceptible strains can also 
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acquire resistance at a relative high frequency upon exposure to bacteriocins (Gravesen et al., 
2002). Compositional changes in the cell membrane that result in modifications of the bacterial 
surface charge has been associated to the resistance to class IIa bacteriocins (Vadyvaloo et al. 
2004), but downregulation of some genes from the mannose PTS operon also results in 
bacteriocin resistance (Tessema et al., 2009). 
The behaviour of L. monocytogenes CECT 5672 was somewhat different (Fig. 2b). This 
strain grew rapidly in milk at 37 ºC and slow growth occurred at 4 ºC. The presence of E. 
faecium MMRA prevented L. monocytogenes proliferation but did not reduce viable counts 
during the first 24 h. Later on, upon cold storage, a reduction of CECT 5672 by 1 log10 unit was 
detected. This strain was slightly less sensitive to enterocin A than CECT 4032, which might 
have accounted for a higher rate of survival, as previously described for nisin resistant variants 
(Martínez et al., 2005). It cannot be ruled out that a higher resistance to pH could have also 
influenced the survival rate. However, both strains were isolated from a dairy environment 
where a low pH is often encountered. These results also point to the fact that the success of 
bacteriocin intervention strategies depends largely on the differing susceptibilities of target 
strains to the bacteriocins (Katla et al., 2003). Despite this, the use of bacteriocinogenic strains 
to inhibit L. monocytogenes growth in dairy products has been successful (Sulzer & Busse, 
1991; Rodríguez et al., 1997; Callewaert et al., 2000; García et al., 2004; Foulquié Moreno et al., 
2006).  
 
5. Conclusions 
Our results have shown that the enterocin A producer E. faecium MMRA isolated from Rayeb 
should be regarded as a potential protective adjunct culture. This strain lacks haemolytic 
activity, known antibiotic resistance genes and several significant virulence factors. It grew 
competitively in raw milk, was able to produce the bacteriocin in situ and suppressed the growth 
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of L. monocytogenes, thus decreasing the risk of Rayeb contamination by this foodborne 
pathogen. This study also provides data concerning gross composition and sugar; organic acid 
and volatile fractions of Rayeb. Thus, the combination of E. faecium MMRA with the 
indigenous raw milk microbiota seems to be suitable for enhancing the hygienic conditions of 
traditional Rayeb and could help to preserve the traditional characteristics typical of this 
fermented dairy product. Finally, it should be noted that as far as we know, this is the first study 
about the use of a bacteriocin-producing strain to control the contamination of North African 
fermented dairy products by L. monocytogenes. 
 
Acknowledgements.  
This work has been partially funded by grant BIO2007-65061 from Ministerio de Ciencia e 
Innovación (Spain). Amel Rehaiem is the recipient of a MAEC-AECID fellowship (Spain). We 
thank Ana Herrero and María Fernández (IPLA-CSIC, Spain) for their technical assistance on 
biogenic amine determination and for supplying the specific primers. Luis Cintas (Universidad 
Complutense de Madrid, Spain) and Manuel Martínez-Bueno (Universidad de Granada, Spain) 
are also thanked for sharing primers, strains and DNA used as positive controls, respectively. 
The English usage in the manuscript has been revised by Emma Meader (Institute of Food 
Research, UK). 
 
References 
Abriouel H, Ben Omar N, Cobo Molinos A, Lucas López R, Grande, MJ, Martínez-Viedma P, 
Ortega E, Martínez Cañamero M & Gálvez A (2008) Comparative analysis of genetic diversity 
and incidence of virulence factors and antibiotic resistance among enterococcal populations 
 19 
from raw fruit and vegetable foods, water and soil, and clinical samples. International Journal of 
Food Microbiology, 123, 38–49. 
Andrighetto C, Knijff E, Lombardi A, Torriani S, Vancanneyt,M, Kersters K, Swings J & 
Dellaglio F (2001) Phenotypic and genetic diversity of enterococci isolated from Italian cheeses. 
Journal of Dairy Research, 68, 303-316.  
Arora G, Lee BH & Lamoureux M (1990) Characterisation of enzyme profiles of Lactobacillus 
casei species by rapid API ZYM system. Journal of Dairy Science 73, 264–273. 
Aureli P, Fiorucci GC, Caroli D, Marchiaro G, Novara O, Leone L & Salmaso S (2000) An 
outbreak of febrile gastroenteritis associated with corn contaminated with Listeria 
monocytogenes. The New England Journal of Medicine, 342, 1236-1241. 
Aymerich T, Holo H, Havarstein LS, Hugas M, Garriga M & Nes IF (1996). Biochemical and 
genetic characterization of enterocin A from Enterococcus faecium, a new antilisterial 
bacteriocin in the pediocin family of bacteriocins. Applied and Environmental Microbiology, 62, 
1676–82. 
Barbosa J, Ferreira V & Teixeira P (2009) Antibiotic susceptibility of enterococci isolated from 
traditional fermented meat products. Food Microbiology, 26, 527–532 
Ben Belgacem Z, Abriouel H, Ben Omar N, Lucas R, Martinez-Cañamero M, Gálvez A & 
Manai M (2010) Antimicrobial activity, safety aspects, and some technological properties of 
bacteriocinogenic Enterococcus faecium from artisanal Tunisian fermented meat. Food Control, 
21, 462–470. 
Benkerroum N & Tamime AY (2004) Technology transfer of some Moroccan traditional dairy 
products (lben, jben and smen) to small industrial scale. Food Microbiology, 21, 399–413. 
Bover-Cid S & Holzapfel WH (1999) Improved screening procedure for biogenic amine 
production by lactic acid bacteria. International Journal of Food Microbiology, 53, 33-41.  
 20 
Callewaert R, Hugas M & de Vuyst L. (2000) Competitiveness and bacteriocin production of 
Enterococci in the production of Spanish-style dry fermented sausages. International Journal of 
Food Microbiology, 57, 33-42.  
Comité
 
de l'Antibiogramme de la Société Française
 
de Microbiologie. Recommandations 2008, 
pp 1-50. Coordonnateur: C.J. Soussy. Société Française
 
de Microbiologie, Paris, France. 
Cossart P & Toledo-Arana A (2008) Listeria monocytogenes, a unique model in infection 
biology: an overview. Microbes Infection, 10, 1041–1050. 
Deegan LH, Cotter PD, Hill C & Ross RP (2006) Bacteriocins: Biological tools for bio-
preservation and shelf-life extension. International Dairy Journal, 16, 1058–1071. 
El Marrakchi A, Hamama A & Elotmani F (1993) Occurrence of Listeria monocytogenes in 
milk and dairy products produced or imported into Morocco. Journal of Food Protection, 56, 
256–259. 
Ennahar S, Deschamps N & Richard J (2000) Natural variation in susceptible Listeria strains to 
class IIa bacteriocins. Current Microbiology, 41, 1-4. 
Fernández M, Linares DM & Alvarez MA (2004) Sequencing of the tyrosine decarboxylase 
cluster of Lactococcus lactis IPLA 655 and the development of a PCR method for detecting 
tyrosine decarboxylating lactic acid bacteria. Journal of Food Protection, 67, 2521–2529. 
Fernández M, Flórez AB, Linares DM, Mayo B & Alvarez MA (2006) Early PCR detection of 
tyramine-producing bacteria during cheese production. Journal of Dairy Research, 73, 318–321. 
Fernández, M., Linares, D. M, Rodríguez, A., & Alvarez, M.A., (2007). Factors affecting 
tyramine production in Enterococcus durans IPLA 655. Applied of Microbiology and 
Biotechnology, 73, 1400-1406. 
Foulquié Moreno MR, Sarantinopoulos P, Tsakalidou E & de Vuyst L (2006) The role and 
application of enterococci in food and health. International Journal of Food Microbiology, 106, 
1–24. 
 21 
Franz C, Muscholl-Silberhorn A, Nuha MKY, Vancanneyt M, Swings J & Holzapfel WH (2001) 
Incidence of virulence factors and antibiotic resistance among enterococci isolated from food. 
Applied and Environmental Microbiology, 67, 4385–4389. 
Franz C, Stiles, ME, Schleifer KH & Holzapfel WH (2003) Enterococci in foods-a conundrum 
for food safety. International Journal of Food Microbiology, 88, 105–122.  
Gálvez A, Abriouel H, Lopez RL & Ben Omar N (2007) Bacteriocin-based strategies for food 
biopreservation. International Journal of Food Microbiology, 120, 51–70. 
García MT, Martínez Cañamero M, Lucas R, Ben Omar N, Pulido RP & Galvez A (2004) 
Inhibition of Listeria monocytogenes by enterocin EJ97 produced by Enterococcus faecalis 
EJ97. International Journal of Food Microbiology, 90, 161–170.  
García-Moruno E, Carrascosa AV & Muñoz R (2005) A rapid and inexpensive method for the 
determination of biogenic amines from bacterial cultures by thin-layer chromatography. Journal 
of Food Protection, 68, 625–629. 
Gasson MJ & Eaton TJ (2001) Molecular screening of Enterococcus virulence determinants and 
potential for genetic exchange between food and medical isolates. Applied and Environmental 
Microbiology, 67, 1628–1635. 
Giraffa G (1995) Enterococcal bacteriocins: their potential as anti-Listeria factors in dairy 
technology. Food Microbiology, 12, 291–299. 
Giraffa G (2002) Enterococci from foods. FEMS Microbiology Reviews, 26, 163–171.  
Hamdi TM, Naïm M, Martin P & Jacquet C (2007) Identification and molecular characterization 
of Listeria monocytogenes isolated in raw milk in the region of Algers (Algeria). International 
Journal of Food Microbiology, 116, 190–193. 
Gravesen A, Jydegaard Axelsen AM, Mendes da Silva J, Hansen TB & Knochel S. (2002) 
Frequency of bacteriocin resistance development and associated fitness costs in Listeria 
monocytogenes. Applied Environmental Microbiology, 68, 756–764. 
 22 
IDF Standard 4A (1982) Cheese and processed cheese. Determination of the total solids content 
(Reference Method). 
IDF Standard 149 (1991) Lactic acid starters-Standard of identity.  
IDF Standard 152 (1991) Milk and milk products. Determination of fat content. General 
guidance on the use of butyrometric methods. 
IDF Standard 20B (1993) Milk. Determination of nitrogen content: Part 1. Kjeldahl method. 
Jay JM (1982) Antimicrobial properties of diacetyl. Applied and Environmental Microbiology, 
44, 525-532.  
Katla T, Naterstad K, Vancanneyt M, Swings J & Axelsson. L (2003) Differences in 
susceptibility of Listeria monocytogenes strains to sakacin P, sakacin A, pediocin PA-1, and 
nisin. Applied and Environmental Microbiology, 69, 4431–4437.  
Khan H, Flint S & Yu PL (2010) Enterocins in food preservation. International Journal of Food 
Microbiology, 141, 1-10. 
Klein G (2003) Ecology and antibiotic resistance of enterococci from food and the gastro-
intestinal tract. International Journal of Food Microbiology, 88, 123–131. 
Leistner L (2000) Basic aspects of food preservation by hurdle technology. International Journal 
of Food Microbiology, 55, 181-188.  
Le Jeune C, Lonvaud-Funel A, ten Brink B, Hofstra H & Van der Vossen JM (1995) 
Development of a detection system for histidine decarboxylating lactic acid bacteria based on 
DNA probes, PCR and activity test. Journal of Applied Bacteriology, 78, 316–332.  
Linares D, Fernández M, Martín MC, & Alvarez .A (2009) Tyramine biosynthesis in 
Enterococcus durans is transcriptionally regulated by the extracellular pH and tyrosine 
concentration. Microbial Biotechnology, 6, 625–633.  
 23 
Lou Y, & Yousef AE (1999) Characteristics of Listeria monocytogenes important to food 
processors. In:. Ryser & Marth (eds) Listeria, listeriosis and food safety, pp 131-224. Marcel 
Dekker, New York, USA.  
Lucas P & Lonvaud-Funel A (2002) Purification and partial gene sequence of the tyrosine 
decarboxylase of Lactobacillus brevis IOEB 9809. FEMS Microbiology Letters, 211, 85–89. 
Lundén J, Tolvanen R & Korkeala H (2004) Human Listeriosis Outbreaks Linked to Dairy 
Products in Europe. Journal of Dairy Science, 87, 6–11. 
Mannu L, Paba A, Daga E, Comunian R, Zanetti S, Duprè I & Sechi LA (2003) Comparison of 
the incidence of virulence determinants and antibiotic resistance between Enterococcus faecium 
strains of dairy, animal and clinical origin. International Journal of Food Microbiology, 88, 291–
304. 
Martínez B, Bravo D & Rodríguez A (2005) Consequences of the development of nisin-resistant 
Listeria monocytogenes in fermented dairy products. Journal of Food Protection, 68, 2383–
2388. 
Ogier JC & Serror P (2008) Safety assessment of dairy microorganisms: The Enterococcus 
genus. International Journal of Food Microbiology, 126, 291–301. 
Paulsen IT, Banerjei L, Myers GS, Nelson KE, Seshadri R, Read TD, Fouts DE, Eisen JA, Gill 
SR, Heidelberg JF, Tettelin H, Dodson RJ, Umayam L, Brinkac L, Beanan M, Daugherty S, 
DeBoy RT, Durkin S, Kolonay J, Madupu R, Nelson W, Vamathevan J, Tran B, Upton J, 
Hansen T, Shetty J, Khouri H, Utterback T, Radune D, Ketchum KA, Dougherty BA, Fraser CM 
(2003). Role of mobile DNA in the evolution of vancomycin-resistant Enterococcus faecalis. 
Science, 299, 2071-2074. 
Pérez-Pulido R, Abriouel H, Ben Omar N, Lucas R., Martínez-Cañamero M, A. Gálvez. (2006). 
Safety and potential risks of enterococci isolated from traditional fermented capers Food and 
Chemical Toxicology, 44, 2070–2077. 
 24 
Rehaiem A, Martίnez B, Manai M & Rodrίguez A (2010) Production of enterocin A by 
Enterococcus faecium MMRA isolated from ‘Rayeb’, a traditional Tunisian dairy beverage. 
Journal of Applied Microbiology, 108, 1685-1693.  
Rilla N, Martínez B, Delgado & Rodríguez A (2003). Inhibition of Clostridium tyrobutyricum in 
Vidiago cheese by Lactococcus lactis ssp. lactis IPLA 729, a nisin Z producer”. International 
Journal of Food Microbiology, 85, 23-33. 
Rodriguez JL, Gaya P, Medina M, & Nuñez M (1997) Bactericidal effect of enterocin 4 on 
Listeria monocytogenes in a model dairy system. Journal of Food Protection, 60, 28-32. 
Ryser E (1999) Foodborne listeriosis. In: Ryser & Marth (eds), Listeria, listeriosis and food 
safety, pp 299-358. Marcel Dekker, New York, USA. 
Salazar N, Prieto A, Leal JA, Mayo B, Bada-Gancedo JC, G. de los Reyes-Gavilán C & Ruas-
Madiedo P (2009) Production of exopolysaccharides by Lactobacillus and Bifidobacterium 
strains of human origin, and metabolic activity of the producing bacteria in milk. Journal of 
Dairy Science, 92, 4158–4168. 
Sarantinopoulos P, Andrighetto C, Georgalaki MD, Rea MC, Lombardi A, Cogan TM, 
Kalantzopoulos G, & Tsakalidou E (2001) Biochemical properties of enterococci relevant to 
their technological performance. International Dairy Journal, 11, 621–647. 
Sarantinopoulous P, Leroy F, Leontopoulou E, Georgalaki MD, Kalantzopoulous G, Tsakalidou 
E, & de Vuyst L (2002) Bacteriocin production by Enterococcus faecium FAIR-E 198 in view of 
its application as adjunct starter in Greek Feta cheese making. International Journal of Food 
Microbiology, 72, 125–136. 
Sulzer G, & Busse M (1991) Growth inhibition of Listeria spp. on Camembert cheese by 
bacteria producing inhibitory substances. International Journal of Food Microbiology, 14, 287–
296. 
 25 
Tessema GT, Møretrø T, Kohler A, Axelsson L, & Naterstad K (2009) Complex phenotypic and 
genotypic responses of Listeria monocytogenes strains exposed to the class IIa bacteriocin 
Sakacin P. Applied and Environmental Microbiology. 75, 6973–6980. 
Vadyvaloo V, Hastings JW, van der Merwe MJ & M. Rautenbach (2002) Membranes of class 
IIa bacteriocin-resistant Listeria monocytogenes cells contain increased levels of desaturated and 
short-acyl-chain phosphatidylglycerols. Applied Environmental Microbiology, 68, 5223–5230. 
Valenzuela AS, Ben Omar N, Abriouel H, Lucas López R, Ortega E, Martínez Cañamero M & 
Gálvez A (2008) Risk factors in enterococci isolated from foods in Morocco: Determination of 
antimicrobial resistance and incidence of virulence traits. Food Chemistry and Toxicology, 46, 
2648–2652. 
WHO (World Health Organization) (2007) Food safety and foodborne illness. Fact sheet N°237. 
WHO Media Centre [http://www.who.int/mediacentre/factsheets/fs237/en/].  
 
 
 26 
Figure legends 
Fig.1. Changes in main volatile compounds during Rayeb fermentation process, (a) ethanol; (b) 2-propanol; (c). diacetyl. (White bars, control 
Rayeb manufactured without E. faecium MMRA as adjunct culture); (Grey bars, experimental Rayeb manufactured with E. faecium MMRA). 
Volatile compounds are expressed as relative abundance (peak area of compound/peak area of internal standard). Data reported are means ± 
standard deviations of two replicates. (*P<0.05; **P<0.01; ***P<0.001) 
 
Fig. 2. Effect of the enterocin A-producing E. faecium MMRA on L. monocytogenes CECT 4032 (a) and L. monocytogenes CECT 5672 (b) 
viability in Rayeb. (Dark bars, E. faecium MMRA); (White bars, L. monocytogenes in the presence of E. faecium MMRA); (Grey bars, L. 
monocytogenes in control Rayeb); (♦,) Bacteriocin activity in experimental and control Rayeb (in mm). Bars are the means ± standard 
deviations of two independent experiments. (***P<0.001) 
 
 27 
Table 1 
Susceptibility to antimicrobial agents (disk diffusion method) and enzymatic profile (API Zym system) of E. faecium MMRA 
Antibiotic (µg/disk) Susceptibility
a
 Enzyme Reaction
b
 
Amoxicillin (25) S Alkaline phosphatase ≥ 40 
Ampicillin (30) S Esterase(C4) 20  
Cephalothin(30) S Esterase lipase (C8) 20 
Ceftazidim (30) I Lipase (C14) 0 
Cefazolin (30)  I Leucine aminopeptidase ≥ 40 
Cefotaxim (30) I Valine aminopeptidase ≥ 40 
Cefuroxim (30) S Cystine arylamidase 20 
Ceftriaxon (30) S Trypsin 0 
Cephalothin (30) S α -Chymotrypsin 0 
Carbenicillin (100) S Acid phosphatase ≥ 40 
Chloramphenicol (30) S Naphthol-AS-BI-phosphohydrolase 5 
Gentamicin (10) S α -Galactosidase 0 
Imipenem (10) S β -Galactosidase 20 
Kanamycin (30) S β -Glucuronidase 0 
Ofloxacin (5) S α -Glucosidase 0 
Oxacillin (1) R N-Acetyl- β -glucosaminidase 5 
Penicillin (30)  S α -Mannosidase 0 
Streptomycin (10)  S α -Fucosidase 0 
Tetracyclin (30) S β -Glucosidase 0 
Tobramycin(10)  S   
Vancomycin (30) S   
a
(S-I-R) (sensitive-intermediate-resistant) 
b
Enzyme activity (nM of chromophore released after 6 h of incubation at 37 °C). 
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Table 2 
Primer sequences for PCR amplication of virulence factors genes
a
 and amino decarboxylase genes
b
 in E. faecium MMRA  
Genes Primer Oligonucleotide sequence
c
 Expected amplicon 
size (pb) 
PCR 
amplification 
Aggregation substance agg 
a
 TE3 
TE4 
5’-AAGAAAAAGAAGTAGACCAAC-3’ 
3’-AAACGGCAAGACAAGTAAATA-5’ 
1553 – 
Gelatinase gelE 
a
 TE9 
TE10 
5’-ACCCCGTATCATTGGTTT-3’ 
3’-ACGCATTGCTTT TCCATC-5’ 
419 – 
 
Cytolysin cyl 
a 
 
CylLLs 
CylLLs 
5’-GTGTTGAGGAAATGGAAGCG -3’ 
3’-TCTCAGCCTGAA CATCTCCAC-5’ 
324 
 
– 
Surface protein esp 
a
 TE34 
TE36 
5’-TTGCTAATGCTAGTCCACGAC C-3’ 
3’-GCGTCAACACTTGCATTGCCGAA-5’ 
933 
 
– 
Hialuronidase hyl 
a 
 
Hyl n1 
Hyl n2 
5’-TTGCTAATGCTAGTCCACGACC-3’ 
3’-GCGTCAACACTTGCATTGCCGAA-5’ 
276 – 
 
Tyrosine decarboxylase tdc 
b
 
Tdc1 
Tdc2 
P1-rev 
P2-for 
5’- AACTATCGTATGGATATCAAG-3’ 
5’- TAGTCAACCATATTGAAATCTGG-3’ 
5’- CCRTARTCNGCNATAGCRAARTCNGTRTG -3’ 
5’- GAYATNATNGGNATNGGNYTNGAYCARG-3’ 
720 
 
924 
 
+ 
 
+ 
Histidine-decarboxylase hdc 
b 
JV16HC 
JV17HC 
5’-AGATGGTATTGTTTCTTATG-3’ 
5’- AGACCATACACCATAACCTT-3’ 
367 – 
c
Y = C or T, R = A or G,  
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Table 3. Gross composition of ‘Rayeb’ at 24 h of incubation 
 
Incubation
time (h) 
Type of 
Rayeb 
 
pH 
a
Titratable 
acidity (%) 
b
TS (%) Fat             
(as %TS) 
Protein        
(as %TS)
 
Bacteriocin 
activity 
0 Raw milk 6.65 ± 0.06 0.18 ± 0.01 12.975 ± 0,67 33.35 ± 0.66 20.33 ± 0.65 - 
24 
C 4.24 ± 0.01 0.76 ± 0.05 18.81 ± 1.5 43.94 ± 0.948 51.67 ± 0.45 - 
E 4.25 ± 0.02 0.77 ± 0.04 20.33 ± 0.65 44.57 ± 1.322
 
51.23 ± 2.79
 
+ 
Data are reported as means  standard deviations of two batches. No significant differences were detected between control  
and experimental Rayeb (P>0.05) 
C: Rayeb made with non-inoculated raw milk (control) 
E: Rayeb made with E. faecium MMRA Rif
r 
inoculated raw milk (experimental) 
a
Titratable acidity expressed in g of lactic acid per 100 mL or 100 g  
b
TS, total solids (mg per 100 g) 
 
 30 
Table 4 Counts of the major bacterial populations (log10 CFU/mL) throughout the ‘Rayeb’ manufacturing period  
Incubation 
time (h) 
Type of Rayeb 
(C/E) 
Total viable counts Total lactic 
acid bacteria 
Coliforms Enterococci Enterococci Rif
r 
0 Raw milk 6.64 ± 0.08 6.16 ± 0.10 4.72 ± 0.43 3.84 ± 0.90 0.00 ± 0.00 
12 
C 8.34 ± 0.20 7.74 ± 0.06 4.90 ± 0.48 6.26 ± 0.03 3.07 ± 0.03 
E  8.97 ± 0.09*  9.04 ± 0.84* 4.45 ± 0.39      8.88 ± 0.84**
 
    8.86 ± 0.80***
 
24 
C 8.37 ± 0.13 7.92 ± 0.02 3.71 ± 0.57 5.63 ± 0.26 3.30±0.26 
E    9.87 ± 0.60**    9.58 ± 0.69** 3.30 ± 0.64      9.43 ± 0.55***       9.41 ± 0.65*** 
Data are reported as means  standard deviations of two batches. Significant differences were detected between control and  
experimental Rayeb at 12 and 24 h (*P<0.05; **P<0.01; ***P<0.001) 
C: Rayeb made with non-inoculated raw milk (control) 
E: Rayeb made with E. faecium MMRA Rif
r
 inoculated raw milk (experimental) 
c
Rifampin resistant enterococci were determined in KF supplemented with 100 µg/ml rifampicin
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Table 5 Evolution of carbohydrates and organic acids (mg/L) throughout the ‘Rayeb’ manufacturing period.  
Incubation 
time (h) 
Type of Rayeb 
(C/E) 
Lactose Glucose Galactose Lactic acid Citric acid Formic acid 
0 Raw milk 38,357.7 ± 257.24 39.0 ± 0.57 60.3 ± 0.34 122.2 ± 5.09 1,259.7 ± 11.54 00.0 ± 0.00 
12 
C 28,434.9 ± 203.58 0.00 ± 0.00 53.64 ± 24.23 7,276.0 ± 142.92 224.3 ± 10.78 23.7 ± 0.70 
E 28,212.9 ± 80.48 0.00± 0.00 54.15 ± 31.22 7,375.6 ± 98.35
 
222.4 ± 15.90
 
25.8 ± 0.54
 
24 
C 27,085 ± 218.17 0.00 ± 0.00 37.89 ± 15.62 8,569.2 ± 32,45 0.00 ± 0.00 58.17 ± 5.58 
E 27,351.5 ± 56.18 0.00 ± 0.00 36.99 ± 19.66 8,285.9 ± 91.44 0.00 ± 0.00 59.19 ± 5.58 
Data are reported as means  standard deviations of two batches. No significant differences were detected between control and experimental  
Rayeb at 12 and 24 h (P>0.05) 
C: Rayeb made with non-inoculated raw milk (control) 
E: Rayeb made with E. faecium MMRA Rifr inoculated raw milk (experimental) 
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Fig. 1 (Rehaiem et al.)
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